Probiotec | PBP - Sales Revenues


Probiotec reported AUD113.96M in Sales Revenues for its fiscal semester ending in December of 2023.



Sales Change Date
Akebia Therapeutics USD 57.34M 10.84M Mar/2025
Alaunos Therapeutics USD 2K 2K Mar/2025
Avita Medical AUD 17.61M 805K Dec/2025
Clinuvel Pharmaceuticals AUD 55.92M 23.66M Jun/2024
Dianthus Therapeutics USD 396K 203K Sep/2025
Genetic Signatures AUD 11.19M 5.56M Dec/2025
Ionis Pharmaceuticals USD 203M 46M Dec/2025
Medical Developments International AUD 21.57M 12.04M Dec/2025
Neuren Pharmaceuticals AUD 42.24M 28.1M Dec/2025
Organon & Co USD 1.51B 90M Dec/2025
Paradigm Biopharmaceuticals AUD -8K 441.66K Jun/2025
PYC Therapeutics AUD 11.04M 2.44M Dec/2025
Starpharma Holdings AUD 10.83M 9.12M Dec/2025
Tectonic Therapeutic USD 0 0 Dec/2024
Telix Pharmaceuticals AUD 413.44M 103.71M Dec/2025
Viatris USD 3.7B 60M Dec/2025
Xeris Pharmaceuticals USD 74.38M 2.84M Sep/2025